| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Q Abdool Karim, SS Abdool Karim, JA Frohlich, AC Grobler, C Baxter, ... science 329 (5996), 1168-1174, 2010 | 4152* | 2010 |
| Detection of a SARS-CoV-2 variant of concern in South Africa H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ... Nature 592 (7854), 438-443, 2021 | 1482 | 2021 |
| Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ... Nature 603 (7902), 679-686, 2022 | 1446 | 2022 |
| Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ... medrxiv, 2020.12. 21.20248640, 2020 | 1205 | 2020 |
| Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa JRC Pulliam, C van Schalkwyk, N Govender, A von Gottberg, C Cohen, ... Science 376 (6593), eabn4947, 2022 | 1073 | 2022 |
| Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ... The Lancet 399 (10323), 437-446, 2022 | 1049 | 2022 |
| The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection ES Gray, MC Madiga, T Hermanus, PL Moore, CK Wibmer, NL Tumba, ... Journal of virology 85 (10), 4828-4840, 2011 | 597 | 2011 |
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants MR Abrahams, JA Anderson, EE Giorgi, C Seoighe, K Mlisana, LH Ping, ... Journal of virology 83 (8), 3556-3567, 2009 | 495 | 2009 |
| Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study GE Gray, M Allen, Z Moodie, G Churchyard, LG Bekker, M Nchabeleng, ... The Lancet infectious diseases 11 (7), 507-515, 2011 | 455 | 2011 |
| Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection ES Gray, PL Moore, IA Choge, JM Decker, F Bibollet-Ruche, H Li, ... Journal of virology 81 (12), 6187-6196, 2007 | 418 | 2007 |
| Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired … M Li, JF Salazar-Gonzalez, CA Derdeyn, L Morris, C Williamson, ... Journal of virology 80 (23), 11776-11790, 2006 | 412 | 2006 |
| Sixteen novel lineages of SARS-CoV-2 in South Africa H Tegally, E Wilkinson, RJ Lessells, J Giandhari, S Pillay, N Msomi, ... Nature medicine 27 (3), 440-446, 2021 | 366 | 2021 |
| Transmission of extensively drug-resistant tuberculosis in South Africa NS Shah, SC Auld, JCM Brust, B Mathema, N Ismail, P Moodley, ... New England Journal of Medicine 376 (3), 243-253, 2017 | 343 | 2017 |
| Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates … KA Cohen, T Abeel, A Manson McGuire, CA Desjardins, V Munsamy, ... PLoS medicine 12 (9), e1001880, 2015 | 296 | 2015 |
| Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection PL Moore, N Ranchobe, BE Lambson, ES Gray, E Cave, MR Abrahams, ... PLoS pathogens 5 (9), e1000598, 2009 | 276 | 2009 |
| Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression L Roberts, JAS Passmore, C Williamson, F Little, LM Bebell, K Mlisana, ... Aids 24 (6), 819-831, 2010 | 272 | 2010 |
| Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study F van Loggerenberg, K Mlisana, C Williamson, SC Auld, L Morris, ... PloS one 3 (4), e1954, 2008 | 250 | 2008 |
| Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ... The Journal of infectious diseases 206 (1), 6-14, 2012 | 248 | 2012 |
| Kosakovsky Pond SL, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T. Detection of a SARS-CoV-2 variant of concern in South Africa H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ... Nature 592 (7854), 438-443, 2021 | 215 | 2021 |
| Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ... Sexually transmitted infections 90 (8), 580-587, 2014 | 205 | 2014 |
